Key facts
- This page summarizes Thomas B. Smith MD's Form 4 filing for COLLEGIUM PHARMACEUTICAL, INC (COLL).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Mar 2024, 16:26.
Thomas B. Smith MD - 29 Feb 2024 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)
- Reporting relationship
- EVP and Chief Medical Officer
- Issuer ticker
- COLL
- Reported as of
- 29 Feb 2024
- Net transaction value
- -$36,580
- SEC form
- 4
- Accepted by SEC
- 04 Mar 2024, 16:26:41 UTC
- Prior SEC filing
- 14 Feb 2024
- Next SEC filing
- 17 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Colleen Tupper as Attorney-In-Fact For Thomas B. Smith, MD
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thomas B. Smith MD filed Form 4 for COLLEGIUM PHARMACEUTICAL, INC (COLL) on 04 Mar 2024.
Change
- Previous filing in this sequence was filed on 14 Feb 2024.
- Current net transaction value: -$36,580.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
COLL
transaction
Common Stock
Sale
- Transaction value
- $36,580
- Shares
- -995
- Change %
- -1.5%
- Price
- $36.76
- Shares after
- 63,409
- Date
- 29 Feb 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.